Development and Advancement of Broad-Spectrum Respiratory Antivirals
Abstract
The overall goal of DABRA is to disrupt the paradigm for the treatment of respiratory viral infection through the development of broad-spectrum inhibitors. These antivirals will effectively treat infections caused by multiple respiratory viruses that impact military readiness, including influenza (A and B), coronaviruses, human rhinoviruses, respiratory syncytial virus, and Adenoviruses. In the longer term, we expect these efforts to provide critical proof-of-concept studies that will pave the way for development broad-spectrum therapies for other classes of (non-respiratory) viruses.
Document Details
- Document Type
- Technical Report
- Publication Date
- May 01, 2021
- Accession Number
- AD1145288
Entities
People
- Sumit K Chanda
Organizations
- Sanford Burnham Prebys Medical Discovery Institute